Agilent, 12-1451, TruAlign vessel, 250 mL conversion kit, for Chinese Pharmacopeia, set of 8, for 708-DS

TruAlign vessel, 250 mL conversion kit, for Chinese Pharmacopeia, set of 8, for 708-DS. Includes vessel, adapter, two-piece mini paddle, evaporation cover and manifold adapter

Specifications:
Apparatus Compatibility: Apparatus 2
Instrument Compatibility: 708-DS
Pharmacopoeia: CP
Volume: 250 mL

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
This conversion kit enables seamless adaptation of 250 mL TruAlign vessel technology for compliance with the Chinese Pharmacopeia dissolution testing requirements. Designed specifically for use with the 708-DS dissolution apparatus, the kit includes a set of eight precision-engineered vessels that ensure accurate, reproducible, and efficient dissolution analysis at low media volumes. Ideal for pharmaceutical laboratories engaged in method development, routine quality control, or regulatory submissions targeting the Chinese market, the kit streamlines vessel setup and conversion while maintaining the highest standards of testing integrity. Each vessel is constructed from high-quality materials to minimize cross-contamination and provide exceptional optical clarity for monitoring and automated measurement processes. The set is compatible with existing Agilent vessel covers and sampling systems, facilitating integration into current workflows and enhancing versatility for multi-method research. This product supports analysts performing dissolution profiling or comparative bioavailability studies, particularly when low volume testing or compliance with regional pharmacopeias is required. It is recommended for organizations seeking to optimize their dissolution platforms for global regulatory needs without sacrificing performance, consistency, or throughput. Cross-compatible with Agilent dissolution accessories, the kit is a practical upgrade for increasing laboratory capability and workflow efficiency in small-volume pharmaceutical dissolution testing.